2012 Executive Officer Compensation Arrangements
EX-10.3 3 d369113dex103.htm JAZZ PHARMACEUTICALS PLC 2012 EXECUTIVE OFFICER COMPENSATION ARRANGEMENTS Jazz Pharmaceuticals plc 2012 Executive Officer Compensation Arrangements
Exhibit 10.3
2012 Executive Officer Compensation Arrangements
| Executive Officer | Base Salary Rate(1) | Target Bonus as % of Annual Base Salary Rate | ||||
| Bruce C. Cozadd Chairman and Chief Executive Officer | $ | 750,000 | 100 | |||
| Kathryn E. Falberg Executive Vice President and Chief Financial Officer | $ | 460,000 | 50 | |||
| Russell J. Cox Executive Vice President and Chief Commercial Officer | $ | 390,000 | 50 | |||
| Suzanne Sawochka Hooper(2) Executive Vice President and General Counsel | $ | 465,000 | 50 | |||
| Fintan Keegan(3) Executive Vice President, Technical Operations | € | 265,000 | 50 | |||
| Jeffrey K. Tobias, M.D. Executive Vice President, Research and Development and Chief Medical Officer | $ | 425,000 | 50 | |||
| Karen J. Wilson Vice President, Finance and Principal Accounting Officer | $ | 266,500 | 20-35 | |||
| (1) | Base salary rate beginning on March 1, 2012. |
| (2) | Ms. Hooper assumed her position effective on March 12, 2012. |
| (3) | Mr. Keegan assumed his position effective on August 1, 2012. |
